Biomarker Testing in Advanced Cancer Still Lags Behind Guideline RecommendationsPublished bymedpagetoday.comon •1 min read— Only 35% of patients had any type of biomarker testing to guide use of targeted agentsCancerGastric CancerLiquidMetastatic CancerPancreatic CancerLearn moreShareLegalReport
